Key result
The ALDH2 Glu487Lys polymorphism did not significantly affect the positivity rate of head-up tilt testing supplemented with sublingual nitroglycerin in patients with vasovagal syncope (68.4% vs 70.3%, p=0.77).
Why the study?
ALDH2 metabolizes nitroglycerin used as a stimulant during HUTT, but the effect of the common East Asian ALDH2 Glu487Lys polymorphism on VVS patients undergoing HUTT supplemented with sublingual NTG was unclear.
Does ALDH2 Glu487Lys polymorphism affect the outcome of head-up tilt test supplemented with sublingual nitroglycerin in patients with vasovagal syncope?
Observational (n=199)
No
Does ALDH2 Glu487Lys polymorphism affect the outcome of head-up tilt test supplemented with sublingual nitroglycerin in patients with vasovagal syncope?
Absolute Event Rate: 68.4% vs 70.3%
p-value: p=0.77
ALDH2 polymorphism does not influence HUTT-NTG positivity; leaves open its role in vasovagal syncope susceptibility.
Background and objective: Head-up tilt test (HUTT) is clinically advantageous for diagnosing patients with vasovagal syncope (VVS). Nitroglycerin is mainly used as a stimulant during HUTT, and mitochondrial aldehyde dehydrogenase 2 (ALDH2) is involved in the metabolism of nitroglycerin (NTG). ALDH2 is the most common variant in the East Asian population. This study aimed to assess the effects of ALDH2 Glu487Lys polymorphism (ALDH2 rs671) on VVS patients undergoing HUTT supplemented with sublingual NTG (HUTT-NTG).Methods: Patients with recurrent VVS (at least 2 times) who were admitted to the syncope center of our hospital were enrolled. All VVS patients have undergone HUTT. The polymorphism of Glu487Lys gene (rs671) of ALDH2 was measured by the TaqMan polymerase chain reaction (PCR). The results of HUTT-NTG of VVS patients with different ALDH2 genotypes were compared and their hemodynamic characteristics were assessed.Results: A total of 199 VVS patients were enrolled, including 101 patients in the ALDH2*1/*1 group and 99 patients in the ALDH2*2 group. Among patients undergoing HUTT-NTG, 70.3% of patients in the ALDH2*1/*1 group and 68.4% of patients in the ALDH2*2 group were positive, and the difference between the two groups was not statistically significant (P=0.77). The proportions of VASIS I, VASIS II, and VASIS III were 40.6%，8.9%，and 20.8% in the ALDH2*1/*1 group, respectively, and the corresponding proportions in the ALDH2*2 group were 36.7%, 11.2%, and 20.4%, respectively. There was no statistically significant difference between the two groups (P=0.91). The hemodynamic characteristics of different genotypes in VVS patients undergoing HUTT-NTG were compared, and no statistically significant difference was found. The median time of syncopal episode occurred after NTG administration in the ALDH2*1/*1 group was 6 min (interquartile range [IQR]: 5.0-9.0), and it was 6.0 min in the ALDH2*2 group (IQR: 4.25-8, P = 0.64).Conclusion: ALDH2 Glu487Lys polymorphism did not affect the outcome of VVS patients undergoing HUTT-NTG, and no significant change in the hemodynamic characteristics of different genotypes was found.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2022) conducted an observational in Vasovagal syncope (n=199). ALDH2 Glu487Lys polymorphism (ALDH2*2 genotype) vs. ALDH2*1/*1 genotype (wild-type) was evaluated on Positive result during head-up tilt test supplemented with sublingual nitroglycerin (p=0.77). The ALDH2 Glu487Lys polymorphism did not significantly affect the positivity rate of head-up tilt testing supplemented with sublingual nitroglycerin in patients with vasovagal syncope (68.4% vs 70.3%, p=0.77).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: